Optical coherence tomography in Huntington's disease: a potential biomarker for cognitive decline?

被引:0
|
作者
Monteiro, A. [1 ]
Costa, A. [1 ]
Andrade, C. [1 ]
Beato, J. [2 ]
Penas, S. [2 ]
Guimaraes, J. [1 ]
Reis, F. [2 ]
Garrett, C. [1 ]
机构
[1] Ctr Hosp Sao Joao, Neurol, Oporto, Portugal
[2] Ctr Hosp Sao Joao, Ophthalmol, Oporto, Portugal
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1234
引用
收藏
页码:190 / 190
页数:1
相关论文
共 50 条
  • [41] Optical coherence tomography as a progression marker in mild cognitive impairment and Alzheimer's disease
    Herrera, L.
    Cruz, N.
    Zabadani, K.
    Caramello, C.
    Ascaso, F. J.
    Minguez, E.
    Casas, P.
    Cristobal, J. A.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [42] RETINAL LAYERS' THICKNESS AS A POTENTIAL BIOMARKER OF HUNTINGTON'S DISEASE
    Kopishinskaya, Svetlana
    Svetozarskiy, Sergey
    Kolchanova, Maria
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A40 - A40
  • [43] Eye-tracking as a potential biomarker in Huntington's disease
    Hanson, J. M.
    Duff, K.
    Hollingworth, A.
    Ramza, N.
    Paradiso, S.
    Paulsen, J. S.
    MOVEMENT DISORDERS, 2008, 23 (01) : S187 - S188
  • [44] Cognitive decline in Huntington's disease is associated with CAG repeat length
    Hellman, A.
    Durbin-Johnson, B.
    Chen, X.
    Harvey, D.
    Decarli, C.
    Tempkin, T.
    Wheelock, V.
    MOVEMENT DISORDERS, 2012, 27 : S55 - S56
  • [45] Cognitive Dysfunction and Decline in Juvenile-Onset Huntington's Disease
    Al-Kaylani, Hend
    Langbehn, Kathleen E.
    van der Plas, Ellen
    Bowren, Mark D.
    Epping, Eric
    Nopoulos, Peggy
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 12 - 12
  • [46] COGNITIVE DECLINE IN HUNTINGTON'S DISEASE (HD) IN COMPUTERIZED ARITHMETIC TASK
    Lunven, Marine
    Hamel, Jennifer
    Lemoine, Laurie
    Youssov, Katia
    Gabadinho, Alexis
    Reilmann, Ralf
    Busse, Monica
    Craufurd, David
    Rosser, Anne
    Massart, Renaud
    Bachoud-Levi, Anne-Catherine
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A51 - A51
  • [47] Cognitive and Functional Decline in Huntington's Disease: Dementia Criteria Revisited
    Peavy, Guerry M.
    Jacobson, Mark W.
    Goldstein, Jody L.
    Hamilton, Joanne M.
    Kane, Amy
    Gamst, Anthony C.
    Lessig, Stephanie L.
    Lee, J. C.
    Corey-Bloom, Jody
    MOVEMENT DISORDERS, 2010, 25 (09) : 1163 - 1169
  • [48] Does pallidal neuromodulation influence cognitive decline in Huntington’s disease?
    Emily Sanrey
    Valérie Macioce
    Victoria Gonzalez
    Laura Cif
    Fabienne Cyprien
    Emilie Chan Seng
    Philippe Coubes
    Gaetan Poulen
    Journal of Neurology, 2021, 268 : 613 - 622
  • [49] MAPT genotype and its influence on cognitive decline in Huntington's disease
    Vuono, R.
    Winder-Rhodes, S. E.
    Sawcer, S. J.
    Barker, R. A.
    MOVEMENT DISORDERS, 2012, 27 : S61 - S62
  • [50] ECOG: DIGITALISED ASSESSMENT OF COGNITIVE DECLINE IN HUNTINGTON'S DISEASE (HD)
    Massart, Renaud
    Lunven, Marine
    Hamet, Jennifer
    Gabadinho, Alexis
    Reilmann, Ralf
    Busse, Monica
    Craufurd, David
    Rosser, Anne
    Audureau, Etienne
    Bachoud-Levi, Anne-Catherine
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A50 - A50